CYP3A4*22 Impairs the Elimination of Ticagrelor, But Has No Significant Effect on the Bioactivation of Clopidogrel or Prasugrel

Clinical Pharmacology and Therapeutics
M T HolmbergM Niemi

Abstract

CYP3A enzymes participate in the elimination of ticagrelor and the bioactivation of clopidogrel and prasugrel. We studied the effects of functional CYP3A genetic variants (CYP3A4*22; rs35599367 and CYP3A5*3; rs776746) on the pharmacokinetics and pharmacodynamics of ticagrelor, clopidogrel, and prasugrel. Six healthy volunteers with the CYP3A4*1/*22 and CYP3A5*3/*3 genotype (CYP3A4*22 carriers), eight with the CYP3A4*1/*1 and CYP3A5*1/*3 genotype (CYP3A5 expressors), and 11-13 with the CYP3A4*1/*1 and CYP3A5*3/*3 genotypes (controls) ingested single doses of ticagrelor, clopidogrel, and prasugrel on separate occasions. Ticagrelor area under the plasma concentration-time curve (AUC) was 89% (P = 0.004) higher in CYP3A4*22 carriers than in controls. CYP3A4*22 carriers also showed more pronounced platelet inhibition at 24 hours after ticagrelor ingestion than the controls (43% vs. 21%; P = 0.029). The CYP3A5 genotype did not affect ticagrelor pharmacokinetics. Neither CYP3A5 nor CYP3A4 genotypes significantly affected prasugrel or clopidogrel. In conclusion, the CYP3A4*22 allele markedly impairs ticagrelor elimination enhancing its antiplatelet effect.

References

Dec 12, 2001·Pharmacogenetics·E HustertL Wojnowski
Jan 18, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jessica L Fayer RehmelBarbara J Ring
Jan 25, 2006·Clinical Pharmacokinetics·Ann K Daly
Sep 19, 2007·Journal of Cardiovascular Pharmacology and Therapeutics·Govinda J WeerakkodyKenneth J Winters
Apr 4, 2008·European Journal of Clinical Pharmacology·Kyoung-Ah KimJi-Young Park
Dec 25, 2008·The New England Journal of Medicine·Tabassome SimonUNKNOWN French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators
Jun 26, 2009·Journal of Thrombosis and Haemostasis : JTH·J J J VAN GiezenP J Greasley
Sep 1, 2009·The New England Journal of Medicine·Lars WallentinMona Thorsén
Jun 17, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Renli TengKathleen Butler
Dec 24, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Diansong ZhouScott W Grimm
Apr 19, 2012·Clinical Pharmacology and Therapeutics·Kathrin KleinUlrich M Zanger
Aug 21, 2012·Basic & Clinical Pharmacology & Toxicology·Virginie AncrenazJules Desmeules
Oct 25, 2012·European Journal of Clinical Pharmacology·Renli TengKathleen Butler
Nov 7, 2012·British Journal of Clinical Pharmacology·Mikko T HolmbergJanne T Backman
Sep 27, 2013·Clinical Pharmacology and Therapeutics·M T HolmbergM Niemi
Jan 6, 2015·British Journal of Clinical Pharmacology·Mikko T HolmbergMikko Niemi
May 4, 2015·European Heart Journal·Christoph VarenhorstUNKNOWN PLATO Investigators
Oct 22, 2015·Pharmacogenetics and Genomics·Danxin Wang, Wolfgang Sadee
Jun 21, 2016·IEEE Journal of Biomedical and Health Informatics·Mahdi MarsousiStergios Stergiopoulos
Nov 16, 2017·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Helinä KahmaJanne T Backman
Jul 12, 2018·IEEE Journal of Biomedical and Health Informatics·Mahdi MarsousiStergios Stergiopoulos

❮ Previous
Next ❯

Citations

Sep 26, 2020·Expert Review of Hematology·Jaime Ribeiro-FilhoMarilda Souza Goncalves
May 2, 2021·Expert Opinion on Drug Metabolism & Toxicology·Abdullah Alkattan, Eman Alsalameen
Jun 29, 2021·Frontiers in Neurology·Adel AlhazzaniAmit Kumar
Jul 27, 2021·Frontiers in Genetics·Tessa A M MulderRon H N van Schaik
Feb 4, 2022·Pharmacogenomics·Sasidharan Pillai V AswathyKanniappan Parthasarathy Arun

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.